Table 2 Lipid profile of the symbiotic and placebo groups during pre-ingestion and ingestion of the symbiotic shake

Total Cholesterol (mg/dL)

Group S

229.67 ± 55.51 ^a

175.33 ± 49.09 ^b

188.22 ± 29.03 ^ab

170.33 ± 28.85 ^b

-25.84% (p < 0.05)

Group P

204.00 ± 3.97 ^a

160.56 ± 19.94 ^a

194.67 ± 49.75 ^a

191.44 ± 33.78 ^a

-4.69% (p > 0.05)

HDL-C (mg/dL)

Group S

43.33 ± 12,94 ^a

48.78 ± 13,10 ^a

51.11 ± 15.16 ^a

58.56 ± 11.08 ^a

+35.15% (p > 0.05)

Group P

50.22 ± 18.30 ^a

49.22 ± 14.67 ^a

49.33 ± 18.72 ^a

55.11 ± 14.34 ^a

+9.74% (p > 0.05)

nHDL-C (mg/dL)

Group S

190.44 ± 58.19 ^a

126.56 ± 43.00 ^b

137.11 ± 30.39 ^b

111.78 ± 24.68 ^b

-41,30 (p < 0.05)

Group P

153.78 ± 18.21 ^a

111.33 ± 29.06 ^a

145.33 ± 59.96 ^a

136.33 ± 32.79 ^a

-11.35 (p > 0.05)

Triglycerides (mg/dL)

Group S

317.56 ± 101.08 ^a

248.89 ± 62.95 ^ab

204.00 ± 89,90 ^b

199.22 ± 54,60 ^b

-37.27% (p < 0.05)

Group P

239.44 ± 58.38 ^a

217.33 ± 56.47 ^a

226.33 ± 126.23 ^a

198.56 ± 66.07 ^a

-17.07% (p > 0.05)